So is Oxycodone now on the backburner?
Sounds like Oxymorphone got the front stalls and trials for Oxycodone are still being planned.
Maybe I have misread the announcement and am happy to be corrected.
However, I thought that the Oxycodone represented the lion's share of the market although it appears that Oxymorphone is growing rapidly.
Can anyone please explain why the emphasis appears to have shifted?
oxymorphone trials begin, page-7
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |